BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29803994)

  • 1. Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects.
    Angeli A; di Cesare Mannelli L; Lucarini E; Peat TS; Ghelardini C; Supuran CT
    Eur J Med Chem; 2018 Jun; 154():210-219. PubMed ID: 29803994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.
    Carta F; Di Cesare Mannelli L; Pinard M; Ghelardini C; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2015 Apr; 23(8):1828-40. PubMed ID: 25766630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spirocyclic sulfonamides with carbonic anhydrase inhibitory and anti-neuropathic pain activity.
    Kalisha Vali Y; Gundla R; Singh OV; Tamboli Y; Di Cesare Manelli L; Ghelardini C; Al-Tamimi AS; Carta F; Angeli A; Supuran CT
    Bioorg Chem; 2019 Nov; 92():103210. PubMed ID: 31473472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects.
    Angeli A; Di Cesare Mannelli L; Ghelardini C; Peat TS; Bartolucci G; Menicatti M; Carta F; Supuran CT
    Eur J Med Chem; 2019 Sep; 177():188-197. PubMed ID: 31136893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sultam based Carbonic Anhydrase VII inhibitors for the management of neuropathic pain.
    Akgül Ö; Lucarini E; Mannelli LDC; Ghelardini C; D'Ambrosio K; Buonanno M; Monti SM; De Simone G; Angeli A; Supuran CT; Carta F
    Eur J Med Chem; 2022 Jan; 227():113956. PubMed ID: 34731762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations.
    Ivanova J; Balode A; Žalubovskis R; Leitans J; Kazaks A; Vullo D; Tars K; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(3):857-863. PubMed ID: 28024887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-aryl-N'-ureido-O-sulfamates: Potent and selective inhibitors of the human Carbonic Anhydrase VII isoform with neuropathic pain relieving properties.
    Bozdag M; Poli G; Angeli A; Lucarini E; Tuccinardi T; Di Cesare Mannelli L; Selleri S; Ghelardini C; Winum JY; Carta F; Supuran CT
    Bioorg Chem; 2019 Aug; 89():103033. PubMed ID: 31212085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
    Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
    Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
    Angeli A; Carta F; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors.
    Lolak N; Akocak S; Bua S; Koca M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():542-547. PubMed ID: 29462772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
    Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
    Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
    Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
    Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.